| |
|
|
| Name: |
COMMODORE CAPITAL LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10153 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
43 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
MRUS |
Merus Nv |
1 |
- |
$43.72 |
$196,331,000 |
4,360,000 |
13.13% |
65,778,000 |
-387,373 |
7.552 |
N/A |
|
|
VERA |
Vera Therapeutics, Inc. |
2 |
- |
$0.00 |
$136,475,000 |
3,165,000 |
9.13% |
52,654,000 |
-2,285,000 |
7.474 |
N/A |
|
|
NUVL |
Nuvalent, Inc. |
3 |
- |
$0.00 |
$111,716,000 |
1,487,756 |
7.47% |
13,765,000 |
156,719 |
2.262 |
N/A |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
4 |
- |
$0.00 |
$93,323,000 |
2,167,793 |
6.24% |
-6,526,000 |
0 |
2.88 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
5 |
- |
$0.60 |
$71,463,000 |
1,884,084 |
4.78% |
30,918,000 |
0 |
3.08 |
N/A |
|
|
ELVN |
Enliven Therapeutics Ord Shs |
6 |
- |
$0.00 |
$69,889,000 |
3,973,245 |
4.67% |
29,728,000 |
1,071,429 |
9.641 |
N/A |
|
|
PCVX |
Vaxcyte, Inc. |
7 |
- |
$0.00 |
$58,747,000 |
860,000 |
3.93% |
-10,333,000 |
-240,000 |
0.797 |
N/A |
|
|
MNMD |
Mind Medicine |
8 |
New |
$8.35 |
$54,833,000 |
5,833,333 |
3.67% |
54,833,000 |
5,833,333 |
16.418 |
N/A |
|
|
ALPN |
Alpine Immune Sciences Inc |
9 |
- |
$64.97 |
$54,505,000 |
1,375,000 |
3.64% |
23,818,000 |
-235,000 |
2.098 |
N/A |
|
|
ARVN |
Arvinas Holding Company, Llc |
10 |
- |
$34.65 |
$52,632,000 |
1,275,000 |
3.52% |
11,472,000 |
275,000 |
1.854 |
N/A |
|
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
11 |
- |
$38.01 |
$45,497,000 |
1,050,000 |
3.04% |
-25,757,000 |
-500,000 |
1.48 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
12 |
- |
$7.92 |
$43,176,000 |
6,425,000 |
2.89% |
10,448,000 |
858,974 |
6.782 |
N/A |
|
|
PHVS |
Pharvaris N V Ord Shs |
13 |
- |
$0.00 |
$39,865,000 |
1,725,000 |
2.67% |
17,425,000 |
925,000 |
4.165 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
14 |
- |
$37.67 |
$36,366,000 |
866,468 |
2.43% |
8,526,000 |
164,501 |
1.378 |
Diagnostic Substances |
|
|
NKTX |
Nkarta, Inc. |
15 |
- |
$0.00 |
$34,214,000 |
3,165,000 |
2.29% |
16,196,000 |
435,000 |
6.504 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
16 |
- |
$12.88 |
$33,876,000 |
1,934,653 |
2.27% |
-8,030,000 |
10,579 |
3.085 |
N/A |
|
|
CELC |
Celcuity Inc. |
17 |
- |
$16.51 |
$33,609,000 |
1,555,954 |
2.25% |
8,043,000 |
-198,750 |
7.18 |
N/A |
|
|
KURA |
Kura Oncology Inc |
18 |
- |
$22.11 |
$32,528,000 |
1,525,000 |
2.18% |
14,581,000 |
276,938 |
1.821 |
N/A |
|
|
CCCC |
C4 Therapeutics, Inc. |
19 |
- |
$0.00 |
$27,863,000 |
3,410,384 |
1.86% |
6,393,000 |
-389,616 |
6.92 |
N/A |
|
|
ORIC |
Oric Pharmaceuticals, Inc. |
20 |
New |
$0.00 |
$27,500,000 |
2,000,000 |
1.84% |
27,500,000 |
2,000,000 |
2.983 |
N/A |
|
|
ABVX |
Abivax S.A |
21 |
- |
$14.31 |
$27,099,000 |
1,895,003 |
1.81% |
6,822,000 |
0 |
3.056 |
N/A |
|
|
ISR |
IsoRay, Inc. |
22 |
New |
$1.59 |
$25,053,000 |
21,052,631 |
1.68% |
25,053,000 |
21,052,631 |
38.266 |
Medical Instruments &... |
|
|
IMVT |
Immunovant Inc |
23 |
- |
$0.00 |
$24,264,000 |
750,990 |
1.62% |
-17,866,000 |
-249,010 |
0.862 |
N/A |
|
|
KYTX |
Kyverna Therapeutics |
24 |
New |
$13.70 |
$22,659,000 |
912,189 |
1.52% |
22,659,000 |
912,189 |
2.121 |
N/A |
|
|
ENGN |
Engene Holdings Inc. |
25 |
New |
$13.27 |
$21,188,000 |
1,250,000 |
1.42% |
21,188,000 |
1,250,000 |
5.388 |
N/A |
|
|
APGE |
Apogee Therapeutics, Inc. |
26 |
- |
$49.21 |
$19,271,000 |
290,000 |
1.29% |
12,286,000 |
40,000 |
0.604 |
N/A |
|
|
CABA |
Cabaletta Bio, Inc. |
27 |
- |
$0.00 |
$18,766,000 |
1,100,000 |
1.25% |
-24,364,000 |
-800,000 |
2.139 |
N/A |
|
|
AUTL |
Autolus Therapeutics Plc |
28 |
New |
$3.87 |
$14,674,000 |
2,300,000 |
0.98% |
14,674,000 |
2,300,000 |
1.329 |
N/A |
|
|
THRD |
Third Harmonic Bio, Inc. |
29 |
- |
$15.54 |
$11,800,000 |
1,250,000 |
0.79% |
4,047,000 |
543,294 |
3.083 |
N/A |
|
|
NGNE |
Neurogene |
30 |
New |
$3.68 |
$10,180,000 |
200,000 |
0.68% |
10,180,000 |
200,000 |
0.477 |
N/A |
|
|
ADVM |
Adverum Biotechnologies, Inc |
31 |
- |
$7.86 |
$9,295,000 |
657,333 |
0.62% |
1,767,000 |
-9,342,667 |
0.651 |
N/A |
|
|
VTGN |
Vistagen Therapeutics Inc |
32 |
- |
$4.38 |
$8,316,000 |
1,575,000 |
0.56% |
220,000 |
0 |
5.827 |
Biotechnology |
|
|
SNDX |
Syndax Pharmaceuticals Inc |
33 |
- |
$20.66 |
$7,589,000 |
318,851 |
0.51% |
7,589,000 |
318,851 |
0.339 |
N/A |
|
|
SLNO |
Soleno Therapeutics Inc |
34 |
- |
$0.16 |
$7,256,000 |
169,533 |
0.49% |
-20,919,000 |
-530,467 |
0.213 |
N/A |
|
|
HLXB |
Helix Acquisition Corp. Ii |
35 |
New |
$10.25 |
$5,200,000 |
500,000 |
0.35% |
5,200,000 |
500,000 |
2.717 |
N/A |
|
|
MGNX |
Macrogenics Inc |
36 |
New |
$4.26 |
$4,343,000 |
295,020 |
0.29% |
4,343,000 |
295,020 |
0.476 |
Biotechnology |
|
|
ACET |
Adicet Bio, Inc |
37 |
New |
$1.61 |
$3,230,000 |
1,374,320 |
0.22% |
3,230,000 |
1,374,320 |
3.207 |
N/A |
|
|
SABS |
Sab Biotherapeutics |
38 |
- |
$5.94 |
$832,000 |
183,174 |
0.06% |
-427,000 |
-1,648,572 |
0.421 |
N/A |
|
|
DBVT |
DBV Technologies SA |
39 |
- |
$0.61 |
$69,000 |
92,687 |
0% |
-19,000 |
0 |
0.085 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
43 |
Closed |
$32.63 |
$0 |
0 |
0% |
-11,970,000 |
-900,000 |
0 |
N/A |
|
|
RYZB |
Rayzebio, Inc. |
42 |
Closed |
$62.49 |
$0 |
0 |
0% |
-23,851,000 |
-383,638 |
0 |
N/A |
|
|
AKRO |
Akero Therapeutics, Inc. |
41 |
Closed |
$0.00 |
$0 |
0 |
0% |
-13,193,000 |
-565,000 |
0 |
N/A |
|
|
HARP |
Harpoon Therapeutics, Inc. |
40 |
Closed |
$0.89 |
$0 |
0 |
0% |
-17,055,000 |
-1,500,000 |
0 |
N/A |
|
